Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection

NCT04640233 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
1600
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Dr. Reddy's Laboratories Limited

Collaborators